{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:40Z","timestamp":1786994680406,"version":"build-2736575974"},"reference-count":296,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.neubiorev.2019.05.014","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:10:00Z","timestamp":1558174200000},"page":"384-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future"],"prefix":"10.1016","volume":"103","author":[{"given":"Nazzareno","family":"Cannella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4089-2483","authenticated-orcid":false,"given":"Massimo","family":"Ubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bramucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Bifone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ciccocioppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2019.05.014_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2008.08.019","article-title":"Differential activation of the anterior cingulate cortex and caudate nucleus during a gambling simulation in persons with a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project","volume":"100","author":"Acheson","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0010","first-page":"67","article-title":"Ability of baclofen in reducing alcohol craving and intake: II\u2014preliminary clinical evidence","volume":"24","author":"Addolorato","year":"2000","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0741-8329(99)00084-1","article-title":"Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction","volume":"20","author":"Addolorato","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.alcalc.a008160","article-title":"An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group","volume":"31","author":"Addolorato","year":"1996","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9343(01)01088-9","article-title":"Rapid suppression of alcohol withdrawal syndrome by baclofen","volume":"112","author":"Addolorato","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0030","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1530-0277.2009.00956.x","article-title":"Understanding and treating patients with alcoholic cirrhosis: an update","volume":"33","author":"Addolorato","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbr.2014.06.049","article-title":"Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL\/6J mice: pharmacological and molecular evidence of orexin involvement","volume":"272","author":"Alcaraz-Iborra","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnins.2014.00033","article-title":"Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models","volume":"8","author":"Anderson","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.biopsych.2010.09.049","article-title":"Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors","volume":"69","author":"Andrews","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0055","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e3181db38bb","article-title":"Placebo-controlled trial of zonisamide for the treatment of alcohol dependence","volume":"30","author":"Arias","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/npp.2017.53","article-title":"The GABAB positive allosteric modulator ADX71441 attenuates alcohol self-administration and relapse to alcohol seeking in rats","volume":"42","author":"Augier","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fpsyt.2013.00023","article-title":"Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring rats","volume":"4","author":"Ayanwuyi","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0080","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1111\/bph.13280","article-title":"Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats","volume":"172","author":"Ayanwuyi","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.peptides.2013.02.008","article-title":"Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference","volume":"43","author":"Bahi","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopsych.2009.07.026","article-title":"Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus","volume":"67","author":"Barr","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/adb.12139","article-title":"Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: role of orexin receptor 2","volume":"20","author":"Barson","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/978-3-642-28720-6_132","article-title":"Translational approaches to medication development","volume":"13","author":"Bartlett","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s002130051028","article-title":"Corticotropin-releasing factor antagonist attenuates the \"anxiogenic-like\" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats","volume":"145","author":"Basso","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.alcohol.2011.02.306","article-title":"Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal","volume":"45","author":"Bayerlein","year":"2011","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-642-28720-6_203","article-title":"Animal models of excessive alcohol consumption in rodents","volume":"13","author":"Becker","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1098\/rstb.2005.1634","article-title":"Investigations into resting-state connectivity using independent component analysis","volume":"360","author":"Beckmann","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1369-1600.2006.00043.x","article-title":"Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence","volume":"12","author":"Benegal","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0135","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41386-017-0007-3","article-title":"Muscarinic M5 receptors modulate ethanol seeking in rats","volume":"43","author":"Berizzi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0140","article-title":"phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol-preferring from genetically heterogenous rats","author":"Bifone","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2008.07071199","article-title":"A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression","volume":"165","author":"Binneman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/acer.12610","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are linked with alcohol consumption in mice and withdrawal and dependence in humans","volume":"39","author":"Blednov","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0160","article-title":"Revisiting intragastric ethanol intubation as a dependence induction method for studies of ethanol reward and motivation in rats","author":"Braconi","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.ALC.0000153544.83656.3C","article-title":"Stress enhancement of craving during sobriety: a risk for relapse","volume":"29","author":"Breese","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2010.09.007","article-title":"Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse","volume":"129","author":"Breese","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0175","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1017\/S1461145713000333","article-title":"Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats","volume":"16","author":"Brown","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0180","doi-asserted-by":"crossref","first-page":"538","DOI":"10.15288\/jsa.1995.56.538","article-title":"Stress, vulnerability and adult alcohol relapse","volume":"56","author":"Brown","year":"1995","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0185","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1530-0277.2011.01540.x","article-title":"Alcohol and the human brain: a systematic review of different neuroimaging methods","volume":"35","author":"Buhler","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0190","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/npp.2009.37","article-title":"Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system","volume":"34","author":"Cannella","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0195","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s00213-016-4333-7","article-title":"Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats","volume":"233","author":"Cannella","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0200","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2014.05.030","article-title":"Ghrelin alters the stimulatory effect of cocaine on ethanol intake following mesolimbic or systemic administration","volume":"85","author":"Cepko","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0205","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1530-0277.2010.01173.x","article-title":"Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence","volume":"34","author":"Chen","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.pbb.2007.03.009","article-title":"Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout","volume":"86","author":"Chu","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0215","first-page":"1414","article-title":"Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference","volume":"25","author":"Ciccocioppo","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0220","doi-asserted-by":"crossref","DOI":"10.1007\/164_2019_209","article-title":"NOP-related mechanisms in substance use disorders","author":"Ciccocioppo","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1369-1600.2006.00032.x","article-title":"Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism","volume":"11","author":"Ciccocioppo","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-003-1645-1","article-title":"Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin\/orphanin FQ in alcohol-preferring rats","volume":"172","author":"Ciccocioppo","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.biopsych.2006.01.006","article-title":"Buprenorphine reduces alcohol drinking through activation of the nociceptin\/orphanin FQ-NOP receptor system","volume":"61","author":"Ciccocioppo","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00213-002-1380-z","article-title":"Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone","volume":"168","author":"Ciccocioppo","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0245","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s002130050828","article-title":"Effect of nociceptin on alcohol intake in alcohol-preferring rats","volume":"141","author":"Ciccocioppo","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0250","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/npp.2014.113","article-title":"Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat","volume":"39","author":"Ciccocioppo","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0255","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00213-014-3743-7","article-title":"Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats","volume":"232","author":"Cippitelli","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0260","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archpsyc.1981.01780330019001","article-title":"Inheritance of alcohol abuse. Cross-fostering analysis of adopted men","volume":"38","author":"Cloninger","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0265","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1369-1600.2000.tb00207.x","article-title":"Gamma-hydroxybutyric acid in alcohol preference, dependence and withdrawal","volume":"5","author":"Colombo","year":"2000","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/alcalc\/37.5.499","article-title":"The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats","volume":"37","author":"Colombo","year":"2002","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0275","doi-asserted-by":"crossref","DOI":"10.1038\/srep31293","article-title":"Functional and structural brain connectivity of young binge drinkers: a follow-up study","volume":"6","author":"Correas","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0280","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/adb.12418","article-title":"Multi-modal MRI classifiers identify excessive alcohol consumption and treatment effects in the brain","volume":"22","author":"Cosa","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13556210500223132","article-title":"The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system","volume":"10","author":"Cowen","year":"2005","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0290","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1073\/pnas.0601417103","article-title":"Consistent resting-state networks across healthy subjects","volume":"103","author":"Damoiseaux","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0295","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0300","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-019-09183-0","article-title":"Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats","volume":"10","author":"de Guglielmo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0305","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0310","first-page":"687","article-title":"Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis","volume":"16","author":"Delgrange","year":"1992","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0315","first-page":"1678","article-title":"Effects of alcoholism and continued abstinence on brain volumes in both genders","volume":"35","author":"Demirakca","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.alcohol.2011.08.011","article-title":"Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats","volume":"46","author":"Dhaher","year":"2012","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0325","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2018.02.013","article-title":"Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats","volume":"90","author":"Dong","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0330","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biopsych.2017.06.024","article-title":"Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder","volume":"82","author":"Dunlop","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0335","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1530-0277.2010.01392.x","article-title":"Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat","volume":"35","author":"Economidou","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0340","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0000000000000133","article-title":"Moderators of varenicline treatment effects in a double-blind, placebo-controlled trial for alcohol dependence: an exploratory analysis","volume":"9","author":"Falk","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0345","first-page":"558","article-title":"Cortical gray matter loss in treatment-naive alcohol dependent individuals","volume":"26","author":"Fein","year":"2002","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0350","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.neuroimage.2006.06.013","article-title":"Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task","volume":"32","author":"Fein","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0355","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/jpet.111.188714","article-title":"Binding kinetics redefine the antagonist pharmacology of the corticotropin-releasing factor type 1 receptor","volume":"341","author":"Fleck","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0360","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1530-0277.2011.01628.x","article-title":"Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings","volume":"36","author":"Fox","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0365","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hup.2280","article-title":"Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine","volume":"28","author":"Fox","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0370","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.conb.2013.05.005","article-title":"Pharmacotherapy for alcohol dependence: status of current treatments","volume":"23","author":"Franck","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0375","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/npp.2014.294","article-title":"Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings","volume":"40","author":"Fredriksson","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0380","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1523\/JNEUROSCI.3096-06.2006","article-title":"Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats","volume":"26","author":"Funk","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0385","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopsych.2006.03.063","article-title":"Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats","volume":"61","author":"Funk","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0390","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","article-title":"gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study","volume":"16","author":"Gallimberti","year":"1992","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0395","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","article-title":"Pharmacological treatment of alcohol dependence: a review of the evidence","volume":"281","author":"Garbutt","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/awp343","article-title":"Cerebral white matter recovery in abstinent alcoholics\u2014a multimodality magnetic resonance study","volume":"133","author":"Gazdzinski","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0405","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1523\/JNEUROSCI.4985-06.2007","article-title":"3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo [1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism","volume":"27","author":"Gehlert","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0410","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.1153813","article-title":"Neurokinin 1 receptor antagonism as a possible therapy for alcoholism","volume":"319","author":"George","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0415","doi-asserted-by":"crossref","first-page":"17198","DOI":"10.1073\/pnas.0707585104","article-title":"CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats","volume":"104","author":"George","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1369-1600.2008.00111.x","article-title":"Modulation of brain response to emotional images by alcohol cues in alcohol-dependent patients","volume":"13","author":"Gilman","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0425","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/npp.2011.206","article-title":"Subjective and neural responses to intravenous alcohol in young adults with light and heavy drinking patterns","volume":"37","author":"Gilman","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0430","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1369-1600.2011.00383.x","article-title":"The effect of intravenous alcohol on the neural correlates of risky decision making in healthy social drinkers","volume":"17","author":"Gilman","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0435","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.410280608","article-title":"Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography","volume":"28","author":"Gilman","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0440","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1530-0277.2008.00745.x","article-title":"Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats","volume":"32","author":"Gilpin","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0445","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0450","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2015.05.026","article-title":"Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence","volume":"97","author":"Gomez","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0455","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/acer.12499","article-title":"The effects of ghrelin antagonists [D-Lys(3)]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL\/6J mice","volume":"38","author":"Gomez","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0460","first-page":"213","article-title":"Alcohol-attributable deaths and years of potential life lost--11 States, 2006\u20132010","volume":"63","author":"Gonzales","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0465","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroimage.2012.12.015","article-title":"Reduced limbic metabolism and fronto-cortical volume in rats vulnerable to alcohol addiction","volume":"69","author":"Gozzi","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0470","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/WCO.0b013e328306f2c5","article-title":"Resting-state functional connectivity in neuropsychiatric disorders","volume":"21","author":"Greicius","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0475","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/npp.2014.316","article-title":"The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle","volume":"40","author":"Grillon","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0480","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","article-title":"A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence","volume":"23","author":"Gual","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0485","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1369-1600.2007.00050.x","article-title":"Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol","volume":"12","author":"Hansson","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0490","doi-asserted-by":"crossref","first-page":"15236","DOI":"10.1073\/pnas.0604419103","article-title":"Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress","volume":"103","author":"Hansson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0495","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0500","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrn3110","article-title":"Pharmacogenetic approaches to the treatment of alcohol addiction","volume":"12","author":"Heilig","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0505","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.biopsych.2011.07.034","article-title":"Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats","volume":"71","author":"Hermann","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0510","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0893-133X(97)00130-9","article-title":"Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats","volume":"18","author":"Heyser","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0515","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1530-0277.1997.tb03840.x","article-title":"Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm","volume":"21","author":"Heyser","year":"1997","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0520","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1073\/pnas.1506012113","article-title":"Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence","volume":"113","author":"Hirth","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0525","first-page":"41","article-title":"Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats","volume":"9","author":"Holter","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0530","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1530-0277.1997.tb03850.x","article-title":"Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation","volume":"21","author":"Holter","year":"1997","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0535","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s002130051069","article-title":"Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats","volume":"145","author":"Holter","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0540","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2013.00092","article-title":"The CRF system and social behavior: a review","volume":"7","author":"Hostetler","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0545","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-013-3245-z","article-title":"Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice","volume":"231","author":"Hwa","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0550","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.euroneuro.2015.09.019","article-title":"Resting state connectivity in alcohol dependent patients and the effect of repetitive transcranial magnetic stimulation","volume":"25","author":"Jansen","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0555","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.0812809106","article-title":"Requirement of central ghrelin signaling for alcohol reward","volume":"106","author":"Jerlhag","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0560","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.alcohol.2010.10.002","article-title":"The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice","volume":"45","author":"Jerlhag","year":"2011","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3282f3cf70","article-title":"Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats","volume":"19","author":"Ji","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0570","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0575","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2010.10050755","article-title":"Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking","volume":"168","author":"Johnson","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0580","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-002-1002-9","article-title":"Ondansetron reduces the craving of biologically predisposed alcoholics","volume":"160","author":"Johnson","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0585","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0590","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0595","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0600","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2011.03.045","article-title":"The orexin(1) receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats","volume":"1391","author":"Jupp","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0605","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/npp.2016.171","article-title":"Genetic deletion of the Nociceptin\/Orphanin FQ receptor in the rat confers resilience to the development of drug addiction","volume":"42","author":"Kallupi","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0610","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1530-0277.2000.tb04608.x","article-title":"P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking","volume":"24","author":"Kampov-Polevoy","year":"2000","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0615","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroimage.2009.11.076","article-title":"Family history of alcoholism mediates the frontal response to alcoholic drink odors and alcohol in at-risk drinkers","volume":"50","author":"Kareken","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0620","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.ALC.0000122764.60626.AF","article-title":"Alcohol-related olfactory cues activate the nucleus accumbens and ventral tegmental area in high-risk drinkers: preliminary findings","volume":"28","author":"Kareken","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0625","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00213-011-2526-7","article-title":"fMRI of the brain\u2019s response to stimuli experimentally paired with alcohol intoxication","volume":"220","author":"Kareken","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0630","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0893-133X(98)00084-0","article-title":"Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat","volume":"20","author":"Katner","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0635","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1530-0277.2010.01237.x","article-title":"Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons","volume":"34","author":"Kaur","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0640","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.pharmthera.2010.08.011","article-title":"Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models","volume":"128","author":"Kehne","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0645","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archpsyc.1997.01830140090015","article-title":"Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949","volume":"54","author":"Kendler","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0650","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0000000000000246","article-title":"Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders","volume":"35","author":"Knapp","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0655","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2007.04.001","article-title":"Zonisamide decreases ethanol intake in rats and mice","volume":"87","author":"Knapp","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0660","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.alcohol.2003.08.007","article-title":"SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats","volume":"32","author":"Knapp","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0665","first-page":"1605","article-title":"Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats","volume":"25","author":"Koistinen","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0670","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0675","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1054-3589(08)60910-2","article-title":"Circuits, drugs, and drug addiction","volume":"42","author":"Koob","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0680","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2009.11.008","article-title":"The role of CRF and CRF-related peptides in the dark side of addiction","volume":"1314","author":"Koob","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0685","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-444-62619-6.00003-3","article-title":"Neurocircuitry of alcohol addiction: synthesis from animal models","volume":"125","author":"Koob","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0690","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0695","first-page":"263","article-title":"Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology","volume":"16","author":"Koob","year":"2003","journal-title":"Recent Dev. Alcohol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0700","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0705","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02246038","article-title":"Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys","volume":"104","author":"Kornet","year":"1991","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0710","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.ALC.0000075547.77464.76","article-title":"Effects of ondansetron in early-versus late-onset alcoholics: a prospective, open-label study","volume":"27","author":"Kranzler","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0715","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0091-3057(97)00474-7","article-title":"Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking","volume":"59","author":"Krishnan-Sarin","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0720","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.102.041350","article-title":"Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone","volume":"304","author":"Kuzmin","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0725","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/npp.2014.306","article-title":"The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study","volume":"40","author":"Kwako","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0730","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1369-1600.2010.00280.x","article-title":"Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats","volume":"17","author":"Landgren","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0735","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.bjp.0706789","article-title":"The orexin system regulates alcohol-seeking in rats","volume":"148","author":"Lawrence","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0740","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050498","article-title":"Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats","volume":"135","author":"Le","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0745","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0741-8329(87)90005-X","article-title":"Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate","volume":"4","author":"Le Magnen","year":"1987","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0750","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2014.03.019","article-title":"Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation","volume":"76","author":"Leggio","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0755","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fnins.2016.00400","article-title":"Nucleus accumbens shell and mPFC but not insula Orexin-1 receptors promote excessive alcohol drinking","volume":"10","author":"Lei","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0760","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuropharm.2005.11.011","article-title":"The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats","volume":"50","author":"Liang","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0765","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1369-1600.2011.00367.x","article-title":"The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598","volume":"17","author":"Lido","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0770","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0775","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1523\/JNEUROSCI.22-18-07856.2002","article-title":"Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms","volume":"22","author":"Liu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0780","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/jpet.300.3.882","article-title":"Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats","volume":"300","author":"Liu","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0785","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/npp.2014.20","article-title":"Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats","volume":"39","author":"Logrip","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0790","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.alcohol.2012.11.002","article-title":"Reduction of alcohol intake by the positive allosteric modulator of the GABA(B) receptor, rac-BHFF, in alcohol-preferring rats","volume":"47","author":"Loi","year":"2013","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0795","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.alcohol.2018.05.007","article-title":"Anti-addictive properties of COR659 - Additional pharmacological evidence and comparison with a series of novel analogues","volume":"75","author":"Maccioni","year":"2019","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0800","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.alcohol.2007.02.006","article-title":"Cue-induced reinstatement of ethanol seeking in Sardinian alcohol-preferring rats","volume":"41","author":"Maccioni","year":"2007","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0805","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.drugalcdep.2009.12.019","article-title":"The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration","volume":"109","author":"Maccioni","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0810","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1530-0277.2012.01782.x","article-title":"Comparison of the effect of the GABABeta receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats","volume":"36","author":"Maccioni","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0815","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00429258","article-title":"Induction of physical dependence upon ethanol and the associated behavioral changes in rats","volume":"43","author":"Majchrowicz","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0820","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","article-title":"Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene","volume":"73","author":"Mann","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0825","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1530-0277.2008.00690.x","article-title":"Acamprosate: recent findings and future research directions","volume":"32","author":"Mann","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0830","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00001756-200006260-00026","article-title":"Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats","volume":"11","author":"Martin-Fardon","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0835","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1369-1600.2012.00480.x","article-title":"N-(2-methyl-6-benzoxazolyl)-N\u2019-1,5-naphthyridin-4-yl urea (SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking","volume":"19","author":"Martin-Fardon","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0840","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2009.12.027","article-title":"Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: focus on corticotropin-releasing factor, nociceptin\/orphanin FQ, and orexin\/hypocretin","volume":"1314","author":"Martin-Fardon","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0845","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.npp.1300420","article-title":"Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior","volume":"29","author":"Martinez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0850","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1176\/ajp.2007.164.4.622","article-title":"Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine","volume":"164","author":"Martinez","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0855","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0860","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1530-0277.1994.tb00098.x","article-title":"A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence","volume":"18","author":"Mason","year":"1994","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0865","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","article-title":"A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence","volume":"56","author":"Mason","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0870","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0875","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/archpsyc.1969.01740200112015","article-title":"Animal model of depression. I. Review of evidence: implications for research","volume":"21","author":"McKinney","year":"1969","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0880","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1530-0277.1998.tb03718.x","article-title":"The alcohol deprivation effect in the alcohol-preferring P rat under free-drinking and operant access conditions","volume":"22","author":"McKinzie","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0885","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0890","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/jnnp.2006.095869","article-title":"A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry","volume":"78","author":"Mechtcheriakov","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0895","first-page":"245","article-title":"Experimentally induced chronic alcoholic intoxication and its suspension. I. Psychotoxicologic results","volume":"35","author":"Mendelson","year":"1964","journal-title":"Hippokrates"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0900","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1523\/JNEUROSCI.15-08-05439.1995","article-title":"Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis","volume":"15","author":"Merlo Pich","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0905","doi-asserted-by":"crossref","first-page":"249","DOI":"10.15288\/jsa.1992.53.249","article-title":"Long-term follow-up of behavioral self-control training","volume":"53","author":"Miller","year":"1992","journal-title":"J. Stud. Alcohol"},{"issue":"Suppl 2","key":"10.1016\/j.neubiorev.2019.05.014_bib0910","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1046\/j.1360-0443.95.8s2.11.x","article-title":"Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving","volume":"95","author":"Monti","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0915","first-page":"1386","article-title":"Naltrexone\u2019s effect on cue-elicited craving among alcoholics in treatment","volume":"23","author":"Monti","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0920","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.10.018","article-title":"Orexin\/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats","volume":"1654","author":"Moorman","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0925","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1093\/cercor\/bhu134","article-title":"The resting brain of alcoholics","volume":"25","author":"Muller-Oehring","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0930","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal","volume":"33","author":"Myrick","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0935","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2017.01.005","article-title":"Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype","volume":"82","author":"Natividad","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0940","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1176\/appi.ajp.159.8.1265","article-title":"Parental depression: animal models of an adverse life event","volume":"159","author":"Newport","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0945","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/syn.20350","article-title":"Topiramate reduces ethanol consumption by C57BL\/6 mice","volume":"61","author":"Nguyen","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0950","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.lfs.2005.06.003","article-title":"Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?","volume":"78","author":"Nielsen","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0955","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","article-title":"Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis","volume":"291","author":"Nunes","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0960","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/026988119801200103","article-title":"Conditioning factors in drug abuse: Can they explain compulsion?","volume":"12","author":"O\u2019Brien","year":"1998","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0965","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence. A controlled study","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0970","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0091-3057(01)00748-1","article-title":"Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake","volume":"72","author":"Olive","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0975","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(02)01272-4","article-title":"Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release","volume":"437","author":"Olive","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0980","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/acer.13336","article-title":"The role of orexin signaling in the Ventral Tegmental Area and Central Amygdala in modulating binge-like ethanol drinking behavior","volume":"41","author":"Olney","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0985","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2005.10.005","article-title":"Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats","volume":"525","author":"Orru","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0990","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib0995","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jamapsychiatry.2014.3053","article-title":"Naltrexone vs placebo for the treatment of alcohol dependence: a randomized clinical trial","volume":"72","author":"Oslin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1000","first-page":"239","article-title":"Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol","volume":"30","author":"Paille","year":"1995","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/adb.12120","article-title":"Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia","volume":"20","author":"Park","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0741-8329(01)00142-2","article-title":"Effects of nicotine on ethanol dependence and brain damage","volume":"24","author":"Penland","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0269881105056519","article-title":"Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats","volume":"19","author":"Perfumi","year":"2005","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1020","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1530-0277.1995.tb01598.x","article-title":"Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics","volume":"19","author":"Pfefferbaum","year":"1995","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1025","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/acer.13147","article-title":"Proof-of-Concept study to assess the nociceptin receptor antagonist LY2940094 as a new treatment for alcohol dependence","volume":"40","author":"Post","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1176\/ajp.156.1.34","article-title":"Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins","volume":"156","author":"Prescott","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0893-133X(97)00071-7","article-title":"Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain","volume":"17","author":"Primus","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/appi.ajp.2010.10020233","article-title":"Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study","volume":"168","author":"Rando","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1045","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1007\/s00213-014-3519-0","article-title":"Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings","volume":"231","author":"Ray","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-008-1136-5","article-title":"Inhibition of orexin-1\/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats","volume":"199","author":"Richards","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.pbb.2007.10.008","article-title":"MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist","volume":"88","author":"Richardson","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1096\/fj.01-0593com","article-title":"Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol","volume":"16","author":"Rimondini","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1369-1600.2007.00079.x","article-title":"Long-lasting tolerance to alcohol following a history of dependence","volume":"13","author":"Rimondini","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2009.11.007","article-title":"Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence","volume":"67","author":"Roberto","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1075","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1523\/JNEUROSCI.0575-08.2008","article-title":"Cellular and behavioral interactions of gabapentin with alcohol dependence","volume":"28","author":"Roberto","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00000374-200001000-00002","article-title":"Alcohol deprivation effect is prolonged in the alcohol preferring (P) rat after repeated deprivations","volume":"24","author":"Rodd-Henricks","year":"2000","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1085","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodriguez de Fonseca","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1090","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1037\/0021-843X.109.4.738","article-title":"Naltrexone\u2019s effects on reactivity to alcohol cues among alcoholic men","volume":"109","author":"Rohsenow","year":"2000","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/acer.13052","article-title":"A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models","volume":"40","author":"Rorick-Kehn","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1037\/0033-2909.113.1.129","article-title":"Prediction of controlled drinking by alcoholics and problem drinkers","volume":"113","author":"Rosenberg","year":"1993","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1530-0277.2009.01070.x","article-title":"Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats","volume":"34","author":"Ruggeri","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00213-006-0546-5","article-title":"Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats","volume":"189","author":"Sabino","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1115","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.amepre.2015.05.031","article-title":"2010 national and state costs of excessive alcohol consumption","volume":"49","author":"Sacks","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1096-9861(19990607)408:3<365::AID-CNE5>3.0.CO;2-N","article-title":"Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain","volume":"408","author":"Sanchez","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2007.10.009","article-title":"Chronic ethanol consumption in rats produces residual increases in anxiety 4 months after withdrawal","volume":"188","author":"Santucci","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","article-title":"Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence","volume":"53","author":"Sass","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1140","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1007\/s00213-014-3518-1","article-title":"Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals","volume":"231","author":"Schacht","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/npp.2012.195","article-title":"Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues","volume":"38","author":"Schacht","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1150","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/npp.2017.298","article-title":"Dopaminergic genetic variation influences aripiprazole effects on alcohol self-administration and the neural response to alcohol cues in a randomized trial","volume":"43","author":"Schacht","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-011-2201-z","article-title":"Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429","volume":"218","author":"Schank","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nmeth.1582","article-title":"Simultaneous assessment of rodent behavior and neurochemistry using a miniature positron emission tomograph","volume":"8","author":"Schulz","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1165","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1515\/RNS.2011.052","article-title":"Integrating PET with behavioral neuroscience using RatCAP tomography","volume":"22","author":"Schulz","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1170","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/npp.2016.61","article-title":"The CRF1 antagonist verucerfont in anxious alcohol-dependent women: translation of neuroendocrine, but not of anti-craving effects","volume":"41","author":"Schwandt","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/awu305","article-title":"Reduced anterior insula, enlarged amygdala in alcoholism and associated depleted von Economo neurons","volume":"138","author":"Senatorov","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1180","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.biopsych.2010.01.005","article-title":"Effects of the mGlu2\/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence","volume":"67","author":"Sidhpura","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1996.01830080033007","article-title":"Replication of the Stockholm Adoption Study of alcoholism. Confirmatory cross-fostering analysis","volume":"53","author":"Sigvardsson","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0741-8329(89)90059-1","article-title":"Long and short alcohol deprivation: effects on AA and P alcohol-preferring rats","volume":"6","author":"Sinclair","year":"1989","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1195","doi-asserted-by":"crossref","first-page":"863","DOI":"10.15288\/qjsa.1968.29.863","article-title":"Development of an alcohol-deprivation effect in rats","volume":"29","author":"Sinclair","year":"1968","journal-title":"Q. J. Stud. Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse?","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1205","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-28720-6_150","article-title":"Modeling relapse situations in the human laboratory","author":"Sinha","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-3-642-28720-6_150","article-title":"Modeling relapse situations in the human laboratory","volume":"13","author":"Sinha","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1215","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/npp.2008.78","article-title":"Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals","volume":"34","author":"Sinha","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1220","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archgenpsychiatry.2011.49","article-title":"Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes","volume":"68","author":"Sinha","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09595230601036960","article-title":"Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications","volume":"26","author":"Sinha","year":"2007","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/alcalc\/34.2.223","article-title":"Craving for alcohol: findings from the clinic and the laboratory","volume":"34","author":"Sinha","year":"1999","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2007.05.041","article-title":"The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal","volume":"571","author":"Skelton","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2007.01.010","article-title":"Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence","volume":"63","author":"Sommer","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1245","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14656566.2017.1349098","article-title":"Pharmacotherapy of alcoholism - an update on approved and off-label medications","volume":"18","author":"Soyka","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1250","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s007020070068","article-title":"Pharmacological validation of a new animal model of alcoholism","volume":"107","author":"Spanagel","year":"2000","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1255","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/npp.2013.264","article-title":"Acamprosate produces its anti-relapse effects via calcium","volume":"39","author":"Spanagel","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1260","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1265","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopsych.2010.12.010","article-title":"Activation of nuclear PPARgamma receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking","volume":"69","author":"Stopponi","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0741-8329(97)00131-6","article-title":"A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat","volume":"15","author":"Stromberg","year":"1998","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0741-8329(00)00137-3","article-title":"Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption","volume":"23","author":"Stromberg","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071284","article-title":"Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption","volume":"8","author":"Suchankova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1285","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.jcp.0000222512.25649.08","article-title":"The status of disulfiram: a half of a century later","volume":"26","author":"Suh","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-244X-8-22","article-title":"Five-Factor Model personality profiles of drug users","volume":"8","author":"Terracciano","year":"2008","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00213-010-2163-6","article-title":"An acute psychosocial stressor increases drinking in non-treatment-seeking alcoholics","volume":"218","author":"Thomas","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1300","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.euroneuro.2017.08.434","article-title":"Systematic review: baclofen dosing protocols for alcohol use disorders used in observational studies","volume":"27","author":"Thompson","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-010-1775-1","article-title":"Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice","volume":"209","author":"Thorsell","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1310","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.mp.4001813","article-title":"Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples","volume":"11","author":"Treutlein","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1315","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-003-1403-4","article-title":"Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety","volume":"167","author":"Tucci","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1320","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/bs.pbr.2015.07.018","article-title":"Emerging targets for addiction neuropharmacology: from mechanisms to therapeutics","volume":"224","author":"Ubaldi","year":"2016","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1325","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2015.04.021","article-title":"Activation of Hypocretin-1\/Orexin-A neurons projecting to the bed nucleus of the stria terminalis and paraventricular nucleus is critical for reinstatement of alcohol seeking by neuropeptide S","volume":"79","author":"Ubaldi","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugalcdep.2010.01.005","article-title":"A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys","volume":"109","author":"Vallender","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1335","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1340","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.alcohol.2014.03.002","article-title":"The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice","volume":"48","author":"Vengeliene","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1345","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biopsych.2010.05.029","article-title":"Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats","volume":"68","author":"Vengeliene","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/01.ALC.0000075829.81211.0C","article-title":"A comparative study on alcohol-preferring rat lines: effects of deprivation and stress phases on voluntary alcohol intake","volume":"27","author":"Vengeliene","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1355","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00213-018-4893-9","article-title":"Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction","volume":"235","author":"Vengeliene","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1360","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/ajp.149.8.1016","article-title":"Decreased brain metabolism in neurologically intact healthy alcoholics","volume":"149","author":"Volkow","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1365","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/ajp.151.2.178","article-title":"Recovery of brain glucose metabolism in detoxified alcoholics","volume":"151","author":"Volkow","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1370","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1530-0277.1997.tb04449.x","article-title":"Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification","volume":"21","author":"Volkow","year":"1997","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1375","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1360-0443.2010.03022.x","article-title":"Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum","volume":"105","author":"Vollstadt-Klein","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1380","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1385","first-page":"138","article-title":"Treating problem drinking","volume":"23","author":"Walitzer","year":"1999","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1390","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0091-3057(82)90459-2","article-title":"Induction of dependence on ethanol by free-choice drinking in alcohol-preferring rats","volume":"16","author":"Waller","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1395","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1530-0277.2000.tb02061.x","article-title":"Regional brain metabolism during alcohol intoxication","volume":"24","author":"Wang","year":"2000","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1400","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0028-3908(97)00118-4","article-title":"The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome","volume":"36","author":"Watson","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S146114571200017X","article-title":"Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects","volume":"16","author":"Weerts","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03556.x","article-title":"Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors","volume":"937","author":"Weiss","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1415","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1530-0277.2012.01845.x","article-title":"The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats","volume":"36","author":"Wen","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1420","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1430","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2013.10.011","article-title":"The biology of Nociceptin\/Orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence","volume":"141","author":"Witkin","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nicl.2016.10.019","article-title":"Cingulate cortex functional connectivity predicts future relapse in alcohol dependent individuals","volume":"13","author":"Zakiniaeiz","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1440","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/adb.12272","article-title":"Model-free functional connectivity and impulsivity correlates of alcohol dependence: a resting-state study","volume":"22","author":"Zhu","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1445","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/hbm.22951","article-title":"Resting-state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence","volume":"36","author":"Zhu","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1450","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1038\/npp.2016.60","article-title":"Opioid antagonists and the A118G polymorphism in the mu-opioid receptor gene: effects of GSK1521498 and naltrexone in healthy drinkers stratified by OPRM1 genotype","volume":"41","author":"Ziauddeen","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1455","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-3-642-28720-6_149","article-title":"Modeling alcohol self-administration in the human laboratory","volume":"13","author":"Zimmermann","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1460","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/alcalc\/agv129","article-title":"Orexin in patients with alcohol dependence treated for relapse prevention: a pilot study","volume":"51","author":"Ziolkowski","year":"2016","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1465","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1517\/13543784.13.7.799","article-title":"The therapeutic potential of CRF1 antagonists for anxiety","volume":"13","author":"Zorrilla","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1470","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yfrne.2014.01.001","article-title":"Corticotropin releasing factor: a key role in the neurobiology of addiction","volume":"35","author":"Zorrilla","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1475","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002130100773","article-title":"Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats","volume":"158","author":"Zorrilla","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.05.014_bib1480","first-page":"59","article-title":"Sensation seeking and the endogenous deficit theory of drug abuse","volume":"74","author":"Zuckerman","year":"1986","journal-title":"NIDA Res. Monogr."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418309837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418309837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:40:47Z","timestamp":1758966047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763418309837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":296,"alternative-id":["S0149763418309837"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.05.014","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}